Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RSBN1 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
mRNA | ZNF253 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
mRNA | DYRK1B | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | SPPL2B | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | ATP2B3 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | CTC-273B12.7 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | CADM4 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
mRNA | C18orf25 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | RNF138 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
mRNA | MYT1 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |